AC
TNXP icon

Armistice Capital’s Tonix Pharmaceuticals TNXP Stock Holding History

Armistice Capital’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-153
Closed -$91K – 379
2024
Q1 		$91K Sell
153
-1,025
-87% -$1.1M ﹤0.01% 309
2023
Q4 		$1.52M Buy
1,178
+725
+160% +$1.17M 0.02% 163
2023
Q3 		$790K Buy
+453
New +$1.66M 0.01% 151

Other funds holding TNXP

Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital's TNXP Position: Q2 2024 in Review

Armistice Capital sold out of Tonix Pharmaceuticals (TNXP) in Q2 2024, closing a stake of 153 shares — an estimated $91K sold.

Armistice Capital first reported a position in TNXP in Q3 2023 and held it in 3 quarters. The position peaked at $1.52M in Q4 2023. 13 funds tracked by Wall St. Rank hold TNXP as of Q2 2024.

  • Armistice Capital reported no remaining Tonix Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Armistice Capital sold 153 Tonix Pharmaceuticals shares in Q2 2024, an estimated $91K.
  • Armistice Capital first reported a position in Tonix Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Armistice Capital's Tonix Pharmaceuticals position peaked at $1.52M in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.